Skip to main content

HIV Cure Challenger CytoDyn Takes On The Gilead Sciences

CytoDyn Inc. announced in a Proactive Investors video a major advancement in HIV whose message that may have gotten buried due to a lengthy disclosure about a fake new article that was promulgated by short seller Citron Research.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.